Class information for:
Level 1: LEISHMANIA//MILTEFOSINE//ANTIMONY RESISTANCE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3390 1995 38.1 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
326 3       LEISHMANIA//TRYPANOSOMA CRUZI//PARASITIOLOGY 38360
108 2             TRYPANOSOMA CRUZI//CHAGAS DISEASE//PARASITIOLOGY 25255
3390 1                   LEISHMANIA//MILTEFOSINE//ANTIMONY RESISTANCE 1995

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LEISHMANIA authKW 595100 20% 10% 396
2 MILTEFOSINE authKW 483523 4% 38% 83
3 ANTIMONY RESISTANCE authKW 339043 1% 92% 24
4 LEISHMANIA DONOVANI authKW 288065 6% 17% 112
5 KALA AZAR MED address 202378 1% 58% 23
6 ANTILEISHMANIAL ACTIVITY authKW 196047 3% 25% 52
7 VISCERAL LEISHMANIASIS authKW 176774 6% 9% 125
8 RECH INFECTIOL address 175923 3% 17% 68
9 PTERIDINE REDUCTASE authKW 161646 1% 81% 13
10 PENTAVALENT ANTIMONIALS authKW 145093 1% 59% 16

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Parasitiology 39971 27% 0% 541
2 Tropical Medicine 18019 14% 0% 286
3 Microbiology 4052 20% 0% 394
4 Pharmacology & Pharmacy 3750 27% 0% 534
5 Chemistry, Medicinal 2545 11% 0% 223
6 Infectious Diseases 1514 9% 0% 177
7 Public, Environmental & Occupational Health 581 8% 0% 165
8 Biochemistry & Molecular Biology 564 18% 0% 359
9 Integrative & Complementary Medicine 199 1% 0% 27
10 Immunology 93 5% 0% 104

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 KALA AZAR MED 202378 1% 58% 23
2 RECH INFECTIOL 175923 3% 17% 68
3 UNIT MOL PARASITOL 127123 1% 46% 18
4 BIOQUIM TRIPANOSOMATIDEOS 103281 1% 38% 18
5 CELLULAR IMMUNOL EXPT THER EUT 102021 1% 67% 10
6 PARASITE IMMUNOL 99464 1% 50% 13
7 KALAAZAR MED 83320 0% 78% 7
8 RAJENDRA MEM MED SCI 53781 1% 23% 15
9 PL TOXINOL ANTIPARASIT DRUGS 48972 0% 80% 4
10 IRD US 084 47822 0% 63% 5

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EXPERIMENTAL PARASITOLOGY 25435 5% 2% 91
2 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 20614 9% 1% 179
3 MOLECULAR AND BIOCHEMICAL PARASITOLOGY 17578 4% 1% 81
4 INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE 13752 1% 8% 12
5 PLOS NEGLECTED TROPICAL DISEASES 10604 3% 1% 57
6 PARASITOLOGY RESEARCH 9297 4% 1% 71
7 IRANIAN JOURNAL OF PARASITOLOGY 6087 1% 3% 15
8 TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 5514 3% 1% 50
9 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 4181 3% 0% 59
10 ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY 4127 1% 1% 29

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 LEISHMANIA 595100 20% 10% 396 Search LEISHMANIA Search LEISHMANIA
2 MILTEFOSINE 483523 4% 38% 83 Search MILTEFOSINE Search MILTEFOSINE
3 ANTIMONY RESISTANCE 339043 1% 92% 24 Search ANTIMONY+RESISTANCE Search ANTIMONY+RESISTANCE
4 LEISHMANIA DONOVANI 288065 6% 17% 112 Search LEISHMANIA+DONOVANI Search LEISHMANIA+DONOVANI
5 ANTILEISHMANIAL ACTIVITY 196047 3% 25% 52 Search ANTILEISHMANIAL+ACTIVITY Search ANTILEISHMANIAL+ACTIVITY
6 VISCERAL LEISHMANIASIS 176774 6% 9% 125 Search VISCERAL+LEISHMANIASIS Search VISCERAL+LEISHMANIASIS
7 PTERIDINE REDUCTASE 161646 1% 81% 13 Search PTERIDINE+REDUCTASE Search PTERIDINE+REDUCTASE
8 PENTAVALENT ANTIMONIALS 145093 1% 59% 16 Search PENTAVALENT+ANTIMONIALS Search PENTAVALENT+ANTIMONIALS
9 PTERIDINE REDUCTASE 1 137738 0% 100% 9 Search PTERIDINE+REDUCTASE+1 Search PTERIDINE+REDUCTASE+1
10 MEGLUMINE ANTIMONIATE 126131 1% 32% 26 Search MEGLUMINE+ANTIMONIATE Search MEGLUMINE+ANTIMONIATE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 CROFT, SL , SUNDAR, S , FAIRLAMB, AH , (2006) DRUG RESISTANCE IN LEISHMANIASIS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 19. ISSUE 1. P. 111-+ 87 61% 687
2 MONGE-MAILLO, B , LOPEZ-VELEZ, R , (2013) THERAPEUTIC OPTIONS FOR VISCERAL LEISHMANIASIS.DRUGS. VOL. 73. ISSUE 17. P. 1863-1888 77 73% 23
3 SINGH, OP , SINGH, B , CHAKRAVARTY, J , SUNDAR, S , (2016) CURRENT CHALLENGES IN TREATMENT OPTIONS FOR VISCERAL LEISHMANIASIS IN INDIA: A PUBLIC HEALTH PERSPECTIVE.INFECTIOUS DISEASES OF POVERTY. VOL. 5. ISSUE . P. - 76 66% 2
4 DORLO, TPC , BALASEGARAM, M , BEIJNEN, JH , DE VRIES, PJ , (2012) MILTEFOSINE: A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN THE TREATMENT OF LEISHMANIASIS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 67. ISSUE 11. P. 2576 -2597 79 52% 133
5 OUELLETTE, M , DRUMMELSMITH, J , PAPADOPOULOU, B , (2004) LEISHMANIASIS: DRUGS IN THE CLINIC, RESISTANCE AND NEW DEVELOPMENTS.DRUG RESISTANCE UPDATES. VOL. 7. ISSUE 4-5. P. 257-266 73 74% 203
6 LOISEAU, PM , BORIES, C , (2006) MECHANISMS OF DRUG ACTION AND DRUG RESISTANCE IN LEISHMANIA AS BASIS FOR THERAPEUTIC TARGET IDENTIFICATION AND DESIGN OF ANTILEISHMANIAL MODULATORS (RETRACTED ARTICLE. SEE VOL 7, PG 455, 2007).CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 6. ISSUE 5. P. 539 -550 92 65% 21
7 SANGSHETTI, JN , KHAN, FAK , KULKARNI, AA , AROTE, R , PATIL, RH , (2015) ANTILEISHMANIAL DRUG DISCOVERY: COMPREHENSIVE REVIEW OF THE LAST 10 YEARS.RSC ADVANCES. VOL. 5. ISSUE 41. P. 32376 -32415 96 42% 13
8 ELMAHALLAWY, EK , AGIL, A , (2015) TREATMENT OF LEISHMANIASIS: A REVIEW AND ASSESSMENT OF RECENT RESEARCH.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 17. P. 2259 -2275 108 43% 2
9 SINGH, K , GARG, G , ALI, V , (2016) CURRENT THERAPEUTICS, THEIR PROBLEMS AND THIOL METABOLISM AS POTENTIAL DRUG TARGETS IN LEISHMANIASIS.CURRENT DRUG METABOLISM. VOL. 17. ISSUE 9. P. 897 -919 111 42% 0
10 GUPTA, S , PAL, A , VYAS, SP , (2010) DRUG DELIVERY STRATEGIES FOR THERAPY OF VISCERAL LEISHMANIASIS.EXPERT OPINION ON DRUG DELIVERY. VOL. 7. ISSUE 3. P. 371 -402 104 48% 17

Classes with closest relation at Level 1


Rank Class id link
1 30746 METACASPASE//DYSKINETOPLASTIDY//WITS MALARIA MOL MED HAEMATOL
2 33515 DINITROANILINE//PHOSPHOROTHIOAMIDATE//2R 3S N BENZOYL 3 PHENYLISOSERINE
3 2942 VISCERAL LEISHMANIASIS//KALA AZAR//POST KALA AZAR DERMAL LEISHMANIASIS
4 1108 CUTANEOUS LEISHMANIASIS//LEISHMANIA TROPICA//LEISHMANIA
5 9995 BENZNIDAZOLE//NIFURTIMOX//TRYPANOSOMA CRUZI
6 4372 LIPOPHOSPHOGLYCAN//GP63//LEISHMANIA
7 34583 CHENOPODIUM AMBROSIOIDES//ASCARIDOLE//MASTRUZ
8 14422 TRYPANOTHIONE REDUCTASE//TRYPANOTHIONE//TRYPAREDOXIN
9 556 LEISHMANIA//LEISHMANIA MAJOR//VISCERAL LEISHMANIASIS
10 30310 GLYCOSYL AMINO ALCOHOLS//N ALKYL DIAMINE//CINNAMIC HYDRAZIDE

Go to start page